60 results on '"H. Hamidou"'
Search Results
2. Prevalence, Risk Factors and Economic Impacts of Ruminant Echinococcosis in the Urban Slaughterhouse of Dedougou, Burkina Faso
- Author
-
Séré Modoui, Sanou Evariste Wilfried Ibrahim, Dembélé René, Kaboré Benoît, Kaboré Adama, Tamboura H. Hamidou, and Belem Adrien Marie Gaston
- Abstract
Parasitic diseases in domestic animals are a permanent obstacle for production, food safety and consumer health. The present work was conducted from september 2020 to april 2021 at the Dedougou abattoir to evaluate the prevalence of echinococcosis and the risk factors associated to this pathology in ruminants. Out of 14497 ruminants inspected, the prevalence of echinococcosis was 0.21%. The prevalence of echinococcosis in cattle, goats and sheep was 0.1%, 0.2% and 0.5% respectively, suggesting a significant effect of species on the transmission of the disease (P-value = 0.0203). Sheep were the most susceptible followed by goats. In addition to the animal species, the effect of animal’s age on the level of infestation was also significant, particularly for goats where the prevalence in animals under two years old (0.4%) was relatively higher (P-value=0.0001) than that recorded in animals over two years old (0.06%). Regarding the other risk factors studied, no significant impact was observed. Regarding condemnation, intestines (70.96%), livers (9.67%), and spleens (19.35%) were the organs affected by hydatid cysts and therefore seized. In view of the importance of ours results, control strategies must be put in place against this pathology in the commune in order to further reduce its impact on ruminants and to serve consumers with safe meat.
- Published
- 2022
3. Study of the Prevalence, Risk Factors and Economic Losses Caused by Swine Cysticercosis in Animals Slaughtered in the Dédougou Communal Slaughterhouse, Burkina Faso
- Author
-
Séré Modou, Kan Saturnin Yorossi, Pooda Sié Hermann, Kaboré Benoît, Kaboré Adama, Tamboura H Hamidou, and Belem Adrien Marie Gaston
- Subjects
General Engineering - Abstract
Swine cysticercosis is a zoonotic disease transmissible from pigs to humans. In Burkina Faso, few scientific studies have been performed on this pathology, especially in slaughterhouses which are the main production sites of meat destined to human consumption. This study was carried out in the Dedougou slaughterhouse on 3 350 pigs inspected and diagnosed by tongue and post-mortem examination to assess the prevalence of cysticercosis, its risk factors, and the financial losses incurred by butchers due to seizures operated by the inspectors. Results revealed no cysticercosis-positive pigs by the tongue technique, while the post-mortem inspection detected 25 cases, representing a prevalence of 0.75%, leading to an overall loss of XOF 1 118 425 for the butchers. The incriminating risk factors with a significant effect on disease transmission were sex (p-value = 0.0033) and age (p-value = 0.0183). Given these results, Dedougou's communal authorities and animal health officials should undertake an awareness campaign on the disease and strengthen surveillance measures against illegal slaughter.
- Published
- 2021
4. UNDERGROUND EXPLOSION ACTION: RAPID EXPANSION OF A SPHERICAL CAVITY IN AN ELASTIC MEDIUM
- Author
-
H. Hamidou and M. Sh. Israilov
- Subjects
Physics ,Rapid expansion ,General Physics and Astronomy ,Boundary (topology) ,Velocity factor ,Mechanics ,Poisson distribution ,Action (physics) ,symbols.namesake ,Exact solutions in general relativity ,Mechanics of Materials ,Horn (acoustic) ,symbols ,Boundary value problem - Abstract
An exact analytical solution to the problem of dynamic expansion of a spherical cavity in an elastic medium (soil) with an arbitrary constant speed is obtained. It is assumed that this speed can be large, up to the velocity of propagation of bulk waves in the medium, and therefore the boundary conditions must be set on the moving boundary. The found solution makes it possible to judge the impact (or control the impact) of underground explosions on objects in the “far” zone, at distances significantly exceeding the size of the cavity. Fixed incorrectness in the approximate solution of this problem, given by J. Achenbach and S. Sun. It is found that the approximate solution obtained by the Horn method, which requires a large parameter in the problem, is not valid in some regions of variation of the Poisson’s ratio of the medium and the rate of expansion of the cavity. It is shown that for those values of the indicated parameters at which an approximate solution can be taken, it agrees with the exact solution.
- Published
- 2021
5. Prevalence and Socio-Economic Incidence of Bovine Tuberculosis in a Slaughter Area in the Northern Sudan Region of Burkina Faso
- Author
-
Ouedraogo Oumar, Tianhoun Denté Fidèle, Séré Modou, Kaboré Adama, Tamboura H. Hamidou, and Belem Adrien Marie Gaston
- Published
- 2022
6. GETUG-AFU 22 Phase II Randomized Trial Evaluating Outcomes of Post-Operative Immediate Salvage Radiation Therapy with or without ADT for Patients with Persistently Elevated PSA Level
- Author
-
I. Latorzeff, S. Guerif, F. Castan, E. Meyer, S. Supiot, E. Lagneau, E. Deniaud-Alexandre, P. Ronchin, A. Benyoucef, L. Cartier, H. Hamidou, G. Crehange, P. Pommier, N. Magne, M. Zibouche, E. Gross, G. Ploussard, L. Salomon, and P. Sargos
- Subjects
Cancer Research ,Radiation ,Oncology ,Radiology, Nuclear Medicine and imaging - Published
- 2022
7. Phytochemical Screening and In vitro Anthelmintic Activity of Cassia alata (L) Roxb. on Haemonchus contortus of Small Ruminants in Burkina Faso
- Author
-
Meda Nag-Tiero Roland, Tianhoun Denté Fidèle, Belem A. M. Gaston, Tamboura H. Hamidou, Kabore Adama, and Konate Almamy
- Subjects
biology ,Phytochemical ,Traditional medicine ,Cassia ,medicine ,Anthelmintic ,biology.organism_classification ,In vitro ,Haemonchus contortus ,medicine.drug - Published
- 2020
8. Phytochemical Screening and In vitro Anthelmintic Activity of Cassia alata (L) Roxb. on Haemonchus contortus of Small Ruminants in Burkina Faso.
- Author
-
Denté Fidèle, Tianhoun, primary, Nag-Tiero Roland, Meda, additional, Almamy, Konate, additional, Adama, Kabore, additional, H. Hamidou, Tamboura, additional, and Adrien Marie Gaston, Belem, additional
- Published
- 2020
- Full Text
- View/download PDF
9. Phytochemical composition, acute toxicity and phytohormonal activity of hydroalcoholic extract of Pentadesma butyracea (Clusiaceae Sabine (1824)) seeds
- Author
-
Tindano Basile, Belemtougri G. Raymond, Sawadogo Laya, Doukoure Maya, Tamboura H. Hamidou, and Bayala Balé
- Subjects
0301 basic medicine ,Pharmacology ,Immature male ,030109 nutrition & dietetics ,Traditional medicine ,biology ,Pentadesma butyracea ,Pharmaceutical Science ,Clusiaceae ,Plant Science ,biology.organism_classification ,01 natural sciences ,Acute toxicity ,0104 chemical sciences ,010404 medicinal & biomolecular chemistry ,03 medical and health sciences ,Complementary and alternative medicine ,Phytochemical ,Polyphenol ,Drug Discovery ,Phytochemical composition ,Bioassay - Abstract
Pentadesma butyracea is a rainforest species of Clusiaceae family with multi-values for human healthcare according to previous ethnobotanical survey. In spite of this traditional use of P. butyracea, there is a lack of scientific knowledge of its biological activities. Therefore, the aim of this study was to identify the major phytochemical compounds of P. butyracea hydroalcoholic seeds extract and to assess phyto-hormonal activities. Phyto-chemical screening of dichloromethane and hydroalcoholic seeds extracts were achieved. Subsequently, acute toxicity study was performed on mice to assess extracts safety use. Phyto-hormonal activities of hydroalcoholic extract of seeds were evaluated by uterotrophic and Hershberger’s bioassays. Phyto-chemical screening of seeds of P. butyracea showed the presence of flavonoids, tannins, phytosterols, polyphenols, leucoanthocyanes and fatty acids. Acute toxicity investigation showed no mortality of mice at the dose of 2000 mg/kg. Hydro-alcoholic extract of seeds significantly increased (p
- Published
- 2017
10. ENDOGENOUS PERCEPTIONS AND MEASURES FOR AGROPASTORALISTS' ADAPTATION IN THE SAHELIAN AREA OF BURKINA FASO
- Author
-
Belem A. M. Gaston, Toe Bernadette, Kabore Adama, Sanou Daouda, Legma Boukari, Traore Almamy, and Tamboura H. Hamidou
- Subjects
geography.geographical_feature_category ,Food security ,business.industry ,Climate change ,04 agricultural and veterinary sciences ,Ruminant Livestock ,Climate Change Perceptions ,Endogenous Adaptation Strategies ,Sahelian Area ,Burkina Faso ,Diversification (marketing strategy) ,Pasture ,Geography ,040103 agronomy & agriculture ,0401 agriculture, forestry, and fisheries ,Livestock ,Adaptation ,business ,Socioeconomics ,Productivity ,Local adaptation - Abstract
The study was conducted to understand the perceptions and local adaptation strategies of rural sahelian communities in Burkina Faso to climate change on ruminant rearing practices. For this purpose, the study was carried out in the rural commune of Bani by collecting primary from semi-structured interviews with 143 producers and secondary data of temperature, rainfall and their spatial and temporal evolution from 2005 to 2016. Analysis of these data reveals that 67.13% of the producers are male and 32.86% female, with an average age of 55 ± 0.3 years. These respondents were agropastoralists with an average of 3.5 ha of cultivated land, using traditional seeds (100% of respondents) and improved seeds (58.7%) and rearing local breeds of ruminants. For climate change, respondents notified an increase in temperature and a decrease in rainfall that corroborates the analysis of the meteorological data collected. The consequences of climate change on livestock farmers' resources are food insecurity, lack of pasture, drought and low animal productivity. The local adaptation strategies applied by livestock farmers are the diversification of agro-sylvo-pastoral production (88.11%) and income-generating activities (70%). In the study area, diversification is the strategy adopted by agro-pastoralists to ensure food security and provide income to meet the daily needs of families.
- Published
- 2019
- Full Text
- View/download PDF
11. Effets de supplémentation des feuilles séchées de Calotropis procera (WILLD) R. Br. sur les performances de croissance et la charge parasitaire des ovins en saison pluvieuse au Burkina Faso
- Author
-
Amadou Traoré, A.M. Gaston Belem, Jeanne Millogo, Geneviève Zabré, Peingued-Ouindé Oumarou Kanazoe, H. Hamidou Tamboura, Boukari Legma, Almamy Konate, and Adama Kaboré
- Subjects
biology ,Calotropis procera, supplémentation, GMQ, OPG, ovins, Calotropis procera, supplementation, ADG, EPG, sheep ,Significant difference ,biology.organism_classification ,medicine.disease_cause ,Animal science ,Fodder ,Calotropis procera ,Homogeneous ,Infestation ,medicine ,Digestive tract ,Procera ,Haemonchus contortus - Abstract
L’etude vise a rechercher une solution alternative a la lutte contre les nematodes parasites du tube digestif des ovins en station. Pour cela, deux niveaux de supplementation avec les feuilles sechees de Calotropis procera sur les performances de croissance et la charge parasitaire ont ete etudies en infestation naturelle. Ainsi, 3 lots homogenes de 5 ovins de race Mossi composes d’un temoin (lot A) exploitant uniquement le pâturage naturel et de deux lots B et C supplementes respectivement avec 100 et 200 g de feuilles sechees de C. procera en plus du pâturage naturel ont ete constitues. Les resultats obtenus revelent que le fourrage distribue de C. procera est riche en matieres azotees totales (19,07% de MS) avec un taux moyen de cellulose (23,44% de MS). Les GMQ et les niveaux d’excretion des oeufs n’ont pas releve de difference significative (P˃0,05) entre les trois lots avec la supplementation. Par contre, la supplementation a entraine une baisse importante de H. contortus , T. colubriformis et Cooperia spp dans les feces des lots supplementes compares au lot temoin. L’utilisation de C. procera pourrait donc etre envisagee dans une strategie de lutte ciblee contre ces parasites, notamment H. contortus . © 2017 International Formulae Group. All rights reserved. Mots cles: Calotropis procera , supplementation, GMQ, OPG, ovins English Title: Supplementation effects of Calotropis procera dried leaves on growth performance and strongyle infection of sheep in the rainy season in Burkina Faso English Abstract The study aims at finding an alternative solution to the control of parasitic nematodes of sheep digestive tract in the station. For this, two levels of supplementation with Calotropis procera dried leaves on the growth performances and strongyle infestation were studied in natural infestation. Thus, three homogeneous groups of 5 sheep of Mossi breed composed of control group (lot A) exploiting only the natural grazing and two groups B and C supplemented respectively with 100 and 200 g of C. procera dried leaves in addition to the pasture have been composed. Obtained results reveal that the distributed fodder of C. procera is rich in total nitrogenous matter (19.07% DM) with average cellulose content (23.44% DM). The GMQs and egg excretion levels did not show a significant difference (P˃0.05) between the three groups with supplementation. On the other hand, it induced a significant decrease of Haemonchus contortus , Trichostrongylus colubriformis and Cooperia spp in the fecal matter of the supplemented groups compared with the control group. The use of C. procera could therefore be considered in a targeted control strategy against these parasites, especially H. contortus . © 2017 International Formulae Group. All rights reserved. Keywords: Calotropis procera , supplementation, ADG, EPG, sheep
- Published
- 2018
12. Effets de supplémentation des feuilles séchées de Calotropis procera (WILLD) R. Br. sur les performances de croissance et la charge parasitaire des ovins en saison pluvieuse au Burkina Faso
- Author
-
Kanazoe, Peingued-Ouindé Oumarou, primary, Zabre, Géneviève, additional, Kabore, Adama, additional, Konate, Almamy, additional, Traore, Amadou, additional, Tamboura, H. Hamidou, additional, Belem, A.M. Gaston, additional, Millogo, Jeanne, additional, and Legma, Boukari, additional
- Published
- 2018
- Full Text
- View/download PDF
13. Ethnobotanical Survey and Biological Activities of Two Lactogenic Plants in the Cascades Region of Burkina Faso
- Author
-
Doukoure Maya, Tindano Basile, Armel Herve Nwabo Kamdje, Bayala Balé, Belemtougri G. Raymond, Sawadogo Laya, and Tamboura H. Hamidou
- Subjects
Ficus sycomorus ,Euphorbia ,food ,Traditional medicine ,biology ,Calotropis procera ,Herbaceous plant ,Carica ,biology.organism_classification ,Moraceae ,Medicinal plants ,food.food ,Holarrhena - Abstract
An ethnobotanical survey for a better knowledge of lactogenic plants has been conducted in Cascades region of Burkina Faso. Biological activities of the two most used plants were evaluated. The survey concerned 25 species classified into 22 genera and 19 families. The most represented families were Moraceae, Apocynaceae, Fabaceae-Caesalpinioideae and Malvaceae. The most used species were Euphorbia hirta, Calotropis procera and Ficus sycomorus with respectively 16.98%, 13.21% and 13.21% followed by Ficus platyphylla (9.43%) and Carica papaya, Holarrhena floribunda, Scoparia dulcis, Sorghum bicolor, each with 3.77% of frequency use. Plants organs mostly used for medicinal preparation were leaves, whole plant for herbaceous species, fruits and seeds. The main mode of medicinal preparation was decoction with 60.42% of frequency use. The most route of administration was oral (68.75%). Biological activities evaluation concerned Euphorbia hirta and Calotropis procera which were the most used plants. The acute toxicity of aqueous extracts of Calotropis procera (AECP) and Euphorbia hirta (AEEH) showed a LD50 of 2063 and 603 mg/kg body weight (b.w), respectively. These LD50 values permitted to classify these plants as slightly toxic herbal drugs. The uterotrophic test showed that the AECP and AEEH exhibited estrogenic activity. In conclusion, important medicinal plants in the Cascades region of Burkina Faso were used to stimulate or ameliorate lactation. However further studies must be conducted to confirm the traditional use of these plants.
- Published
- 2018
14. Control of pelvic symptoms in patients with rectal cancer and synchronous metastases
- Author
-
Francis Michot, H. Hamidou, B. Lefebure, F. Di Fiore, David Tougeron, Bernard Paillot, Pierre Michel, and Jean-Jacques Tuech
- Subjects
Male ,medicine.medical_specialty ,Colorectal cancer ,medicine.medical_treatment ,Pelvis ,Metastasis ,medicine ,Humans ,Neoplasm Metastasis ,Aged ,Retrospective Studies ,Chemotherapy ,Rectal Neoplasms ,business.industry ,Gastroenterology ,Cancer ,Retrospective cohort study ,General Medicine ,Middle Aged ,medicine.disease ,Combined Modality Therapy ,Surgery ,Radiation therapy ,medicine.anatomical_structure ,Female ,business ,Chemoradiotherapy - Abstract
The optimal treatment strategy for rectal cancer (RC) with synchronous metastases remains an issue of debate. The aim of this study was to evaluate the impact of surgery and radiation on the control of pelvic symptoms in this setting.Consecutive patients with RC and synchronous metastases were retrospectively assessed and divided into four treatment groups: surgical resection of rectal tumor (S); radiotherapy with/without chemotherapy followed by surgery (CRTS); chemoradiotherapy (CRT); and chemotherapy only (CT). Each group was evaluated in terms of duration of pelvic symptom-free periods (relative to overall survival).A total of 96 patients were evaluated: S: n=30; CRTS: n=21; CRT: n=27; and CT: n=18. After treatment, pelvic symptoms persisted in 14.7% patients (S=0%, CRTS=7.1%, CRT=31.8%, CT=25%; P=0.01). The relative pelvic symptom-free periods were 93.0% in the S group, 83.1% in the CRTS group, 53.0% in the CRT group and 53.2% in the CT group (P0.01). On multivariate analysis, only surgical treatment correlated with a significant relative pelvic symptom-free period (P0.01), with an adjusted hazards ratio of 2.80 [95% CI: 1.79-4.39].Our results suggest that rectal resection was the most effective therapeutic procedure in selected patients with RC and synchronous metastases, offering the patients the longest pelvic symptom-free periods.
- Published
- 2009
15. Contents Vol. 73, 2007
- Author
-
C.E. Nwogu, A.N. Tenekeci, Pierre Michel, Michihide Mitsumori, Kohkichi Hata, Mariana Capurro, S. Maddipatla, R.V. Iyer, Eiji Miyoshi, H.J. Stemmler, Rosangela Romano, A. Douglas-Jones, B. Kalischefski, Sylvie Negrier, D. Laessig, J. Robson, Domenico Germano, Wong Benjamin Chun Yu, Torello Lotti, Chen Minhu, Peixing Wu, Jie Zhang, G. Paganelli, Metin Karakok, Rafael Roesler, P.A. Fasching, Toshinao Onoda, Takatsugu Kan, Tsuneo Tanaka, Hideyuki Ohnuma, Yasuhito Tonomoto, M. Stauch, Sung Ho Choi, Hui Yan Li, R.E. Mansel, C. Poettgen, S. Raj, Yan Wang, Daniela Massi, Xiaoyan Yang, Thomas Krbek, B. Sakar, Bülent Akgul, H. Kynaston, Dipok Kumar Dhar, H. Kölbl, Satoshi Shiojima, Vincenzo De Giorgi, J.D. Black, Bin Zhou, Evangelos Karayiotis, Seungmin Bang, Hong-zhi Luo, Akira Myoumoto, Bing Xu, Hitoshi Nobumasa, Pu Wang, Serena Sestini, Go Watanabe, Yutaka Shimada, Ibrahim Sari, S.R. Davies, Tadashi Kadowaki, Si Young Song, Shinichi Miyamoto, Meletios A. Dimopoulos, Bai Aiping, G. Loewen, P. Maubach, Akira Miyauchi, Shen Benchang, F. Melchert, Shigemi Matsumoto, G. Morack, J. Alkhaddo, N. Natarajan, Atsushi Itami, Zong-guang Zhou, Luise Meurer, Lie Yang, Hai-yi Liu, Naofumi Nagasue, Kanako Yamanaka, Dirk Theegarten, Giulia Lo Russo, Gazi Comez, Aristotle Bamias, M.E. Reid, David Tougeron, Efstathios Kastritis, Eiji Tanaka, A. Chhabra, Sabine Levegruen, Marios Froudarakis, Andreas Koureas, Celalettin Camci, Yavuz Pehlivan, Jeong Youp Park, F. Eid, Dirk Jaeger, Gozoh Tsujimoto, N. Ramnath, A.U. Pande, G. Watkins, H.S. Fernando, H. Meerpohl, Mehmet Emin Kalender, Katsuhisa Noda, Helmut Teschler, Gilberto Schwartsmann, Xiao-Feng Sun, Genny Leporatti, M.A. Ustaoglu, Tetsuo Ito, Martin Stuschke, V. Heinemann, Alper Sevinc, Toshinori Sato, Noriko Okuyama, Bernard Paillot, Olivier Rigal, Yuan Li, Andreas Bockisch, M. Basaran, Nikos Antoniou, P. Dua, Sadako Yamagata, D. Mazhar, Hiroshi Yoshida, Wolfgang Stremmel, S. Saglam, Mei Hou, Wilfried Eberhardt, R.J. Menezes, N.F. Aykan, Michael Chrisofos, Hitoshi Matsumoto, C.M. Levea, Anastassios V. Koutsopoulos, Georgios Stamatis, Hideo Akiyama, Li Xiaoyan, Ling Wang, H. Hamidou, Maurie Markman, Luigi Manzione, Andreas Skolarikos, Yu-jian Zeng, Mario Dini, Jorge Filmus, A.K. Dixon, Frédéric Di Fiore, Daniela Baumann Cornelio, M. Emin Kalender, Stephen J. Meltzer, Wang Jinhui, A. Argon, Tatsuya Yamagata, M. Gumus, Motoshige Higashiyama, B. Weber, Song Xin, G. Alivizatos, Jiang Zhu, Sung Hoon Noh, Thomas Gauler, Yasuhiro Ito, Thomas R. W. Herrmann, Christina Herrmann, Jinghai Zhang, Yong Soo Kim, U. Vehling-Kaiser, H. Mehmet Turk, Z. Ustuner, Hilmar Kuehl, Christelle De La Fouchardiere, Chen Huixin, Woo Jin Hyung, Georgia Karpathiou, M.M. Javle, Olivia Diaz, Evangelia Argiana, A. Scharl, Ulrich Abel, George Lainakis, Fumiaki Sato, W.G. Jiang, M.V. Williams, Romain Coriat, G.Y. Yang, N. Guney, Shiori Tomoda, A. Rani, Françoise Desseigne, Jun-min Song, and Mitsuo Tachibana
- Subjects
Cancer Research ,Oncology ,General Medicine - Published
- 2007
16. Prise en charge des tumeurs des parties molles de l’appareil locomoteur de l’adulte
- Author
-
J. Simonet, P. Vera, Franck Dujardin, C. Guillemet, H. Hamidou, B. Dubray, C. Cambon-Michot, and M. Debled
- Subjects
Surgical margin ,medicine.medical_specialty ,Chemotherapy ,medicine.diagnostic_test ,business.industry ,Soft tissue sarcoma ,medicine.medical_treatment ,Soft tissue ,Magnetic resonance imaging ,General Medicine ,medicine.disease ,Surgery ,Radiation therapy ,Biopsy ,medicine ,Orthopedics and Sports Medicine ,Sarcoma ,business - Abstract
The diagnostic and therapeutic management of patients with soft-tissue tumors would be similar to the approach used for bone tumors if it were not for one crucial factor: the absolute necessity to recognize a sarcoma. The predominant features are the size of the tumor and its superficial or deep localization. If the tumor is small and superficial, biopsy can be associated with immediate resection without risk of dissemination to the deep tissues: this is the biopsy-resection approach. If the tumor is deep or superficial but large sized, search for locoregional spread with MRI is necessary before undertaking any surgical procedure. MRI can help guide the biopsy and plan resection if the tumor is a sarcoma. A first biopsy is necessary to establish the histological diagnosis and elaborate the therapeutic strategy. Samples should be sent immediately to the pathology lab which should examine sterile fresh tissue. Experience has demonstrated that proper rules for diagnosis and treatment are not necessarily applied initially in approximately one-fourth of all subjects with a malignant soft-tissue tumor. Besides the medical problems caused by this situation, the patient loses a chance for cure. When the tumor is a sarcoma, surgery is the basis of treatment. Complementary radiation therapy may be necessary, particularly for high-grade tumors or if the surgical margin was insufficient. Systemic or locoregional chemotherapy can also be used for high-grade or non-resectable tumors.
- Published
- 2006
17. Induction cisplatin–irinotecan followed by concurrent cisplatin–irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial
- Author
-
Pierre Michel, Laetitia Dahan, M.P. Galais, E. Boucher, J.H. Jacob, F. Di Fiore, H. Hamidou, S Prod'Homme, Marie-France Hellot, Bernard Paillot, Antoine Adenis, Xavier Mirabel, and Jean-Luc Raoul
- Subjects
Male ,Cancer Research ,medicine.medical_specialty ,oesophageal cancer ,Esophageal Neoplasms ,medicine.medical_treatment ,Irinotecan ,Clinical Studies ,Antineoplastic Combined Chemotherapy Protocols ,Medicine ,Humans ,exclusive chemo-radiotherapy ,Survival rate ,induction chemotherapy ,Neoplasm Staging ,Chemotherapy ,Performance status ,business.industry ,Remission Induction ,Dose fractionation ,Induction chemotherapy ,Middle Aged ,Combined Modality Therapy ,Surgery ,Survival Rate ,Regimen ,Treatment Outcome ,Oncology ,Carcinoma, Squamous Cell ,Camptothecin ,Female ,Dose Fractionation, Radiation ,Cisplatin ,business ,Deglutition Disorders ,Chemoradiotherapy ,medicine.drug - Abstract
A recent phase I study showed that weekly cisplatin, irinotecan and concurrent radiotherapy can be administered with moderate toxicity in patients with oesophageal cancer. Patients with no prior treatment and oesophageal cancer stage I to III, performance status3, caloric intake1,500 kcal day(-1) were included. Chemotherapy, with cisplatin 30 mg m(-2) and irinotecan 60 mg m(-2), was administered at days 1, 8, 22, 29, and concurrently with radiotherapy at days 43, 50, 64 and 71. Radiotherapy was delivered with 50 or 50.4 Gy in 25 fractions/5 weeks. Forty-three patients were included, 10 stage I, 19 stage II and 14 stage III. Mean age was 59.2 years (range 44-79). A total of 30 out of 43 (69.8%) patients underwent all planned treatment. During induction chemotherapy, 14 severe toxicities of grade 3 or 4 in 10 patients (23.3%) were reported with 57.1% due to haematoxicity. During chemoradiotherapy, 31 severe toxicities of grade 3 or 4 with 64.5% due to haematotoxicity were reported in 18 patients. One toxic death occurred (diarrhoea grade 4). The complete clinical response rate was 58.1% (95% CI: 43.4-72.8%). Overall survival rate at 1 and 2 years was 62.8%, (95% CI, 58.3-77.3%) and 27.9% (95% CI, 13.4-41.3%), respectively. In conclusion, cisplatin-irinotecan-radiotherapy is an active and well-tolerated regimen feasible in out-patients.
- Published
- 2006
18. Impact of radiation schedule and chemotherapy duration in definitive chemoradiotherapy regimen for esophageal cancer
- Author
-
Pierre Michel, Frédéric Di Fiore, Brigitte Vie, Stéphane Lecleire, J.H. Jacob, Isabelle David, Olivier Rigal, Bernard Paillot, H. Hamidou, and Marie-Pierre Galais
- Subjects
Male ,Antimetabolites, Antineoplastic ,medicine.medical_specialty ,Time Factors ,Esophageal Neoplasms ,medicine.medical_treatment ,Antineoplastic Agents ,Adenocarcinoma ,Gastroenterology ,Internal medicine ,medicine ,Carcinoma ,Humans ,Neoplasm Metastasis ,Neoplasm Staging ,Retrospective Studies ,Chemotherapy ,Esophageal disease ,business.industry ,Radiotherapy Dosage ,General Medicine ,Middle Aged ,Esophageal cancer ,medicine.disease ,Combined Modality Therapy ,Surgery ,Radiation therapy ,Regimen ,Treatment Outcome ,Data Interpretation, Statistical ,Concomitant ,Carcinoma, Squamous Cell ,Female ,Fluorouracil ,Cisplatin ,Neoplasm Recurrence, Local ,business ,Chemoradiotherapy ,Follow-Up Studies - Abstract
Summary Impact of radiotherapy (RT) schedule on local response and duration of the 5-fluorouracil/cisplatin (5 FU/CDDP) chemotherapy (CT) on m are still questioning in chemoradiotherapy (CRT) regimen in esophageal carcinoma. Aim Evaluate two RT schedules and two different CT durations by a retrospective comparison of the CRT regimens used by two centres between 1994 and 2000. Methods In centre I (regimen I), patients received 2 CT concomitantly to a continuous RT (50 Gy/25 fractions/5 weeks). In centre II (regimen II), patients received 6 CT, 3 were concomitant to a split course RT (20 Gy/10 fractions x 3 courses) and 3 CT were delivered after CRT. Results A total of 129 patients were included, 74 in centre I and 55 in centre II respectively. Main patient characteristics were similar between the two groups. Clinical complete response to CRT was significantly more frequent in regimen I (83.8% vs 65.4%; P = 0.02). The median overall survival (OS) was 20 months in regimen I and 22 months in regimen II (NS). During follow-up, responder patients to CRT in regimen II experienced significant fewer metastasis (51.6% vs 27.8%; P = 0.03) with a trend to an increased 5-year survival (19.4% vs 11.3%) and OS (26.5 vs 21.0 months) (NS). Grade 3-4 toxicities were not different. Conclusion Clinical complete response to CRT was significantly more frequent with a continuous RT whereas additional CT after CRT significantly reduced metastasis occurrence. CRT regimen in esophageal carcinoma may be more effective using a continuous RT schedule and additional CT courses after CRT completion.
- Published
- 2006
19. Botanical and Ethnoveterinary Surveys of Two Acacias (Acacia raddiana and Acacia nilotica) Exploited in Small Ruminant Rearing in Sahelian Area of Burkina Faso
- Author
-
Hoste Hervé, Livio Martin Costa Junior, Bayala Balé, Zabré Geneviève, Tamboura H. Hamidou, Belem A. M. Gaston, Louvandini Helder, Niderkorn Vincent, and Kabore Adama
- Subjects
0301 basic medicine ,2. Zero hunger ,biology ,Agroforestry ,Animal feed ,business.industry ,Acacia ,General Medicine ,030108 mycology & parasitology ,15. Life on land ,biology.organism_classification ,Arid ,03 medical and health sciences ,Overexploitation ,13. Climate action ,Faidherbia albida ,Livestock ,business ,Balanites aegyptiaca ,Woody plant - Abstract
In Burkina Faso, rural livestock farmers in arid and semi-arid areas rely heavily on woody plant resources such as Acacia nilotica and Acacia raddiana to satisfy the needs of small ruminant rearing. The assessment of the availability and the use of these two species are therefore essential to better manage them sustainably for their preservation. The survey carried out in the area showed that the questioned farmers exploited the leaves and pods of the two Acacia for the needs of the ruminants. 100% of the farmers exploit A. raddiana only for the feeding of small ruminants. However, A. nilotica was exploited for animal feed and health. The most commonly reported treatments are Foot and Mouth Disease (98.7%) followed by diarrhea (73.7%) and foot wounds (51.2%). In order to compare the results of the survey, a botanical inventory was carried out in the area and the results showed that A. raddiana is more available compared to A. nilotica. Also, other local species such as Faidherbia albida, Acacia senegal, Balanites aegyptiaca and Acacia siberiana are also exploited for the needs of small ruminant rearing in the study area. The most important constraints were excessive cutting, drought and overexploitation that negatively impact their survival. Data on these constraints provide the basis for a campaign to raise awareness among herders' communities to preserve these plants to sustainably improve the productivity of small ruminants and consequently farmer’s income.
- Published
- 2017
20. Constraints of Ruminant Rearing and Ethno-veterinary Practice Against African Animal Trypanosomosis in the Pastoral Area of Gaongho in Burkina Faso
- Author
-
Zabré Geneviève, Zongo André, Belem A. M. Gaston, Kabore Adama, Traoré Aristide, Traore Amadou, and Tamboura H. Hamidou
- Subjects
Veterinary medicine ,Pastoral area ,Geography ,biology ,Descriptive statistics ,Health management system ,Ruminant ,Ethnic group ,Context (language use) ,General Medicine ,Rural area ,biology.organism_classification - Abstract
In rural area of Burkina Faso, health management of domestic animals is a constant concern for low-income farmers. In this context, an ethno-veterinary survey was conducted among 62 farmers of ruminant in the pastoral area of Gaongho in Bazega province to understand the rearing practice, to identify the main constraints of and the practices used against African trypanosomosis. For this, data were collected between March to June 2014 using a structured questionnaire and analyzed by descriptive statistics such as mean, frequency and percentages. The results showed that respondents were 48.3% literate and mainly of Fulani ethnic with an average age of 45 years. The main constraints of ruminant rearing for farmers are diseases (86.2%), particularly African Animal Trypanosomosis which is the most dominant (96.7%). To control this pathology, farmers practice modern (100%) and traditional (35.4%) medicine. Seventeen traditional herbal remedies are used to control trypanosomosis of ruminants in the area. Their modes of preparation and administration to ruminants are described according to surveyed farmers.
- Published
- 2017
21. Unusual iris metastasis from anal cancer: A case report
- Author
-
M. Muraine, M. Benzerroug, Z. Nasser, B. Lefebure, David Tougeron, H. Hamidou, B. Tougeron-Brousseau, and Pierre Michel
- Subjects
Systemic disease ,medicine.medical_specialty ,Anal Carcinoma ,medicine.medical_treatment ,urologic and male genital diseases ,medicine ,Humans ,Anal cancer ,cardiovascular diseases ,Iris Neoplasms ,Iris (anatomy) ,Aged ,Hepatology ,urogenital system ,business.industry ,Medical record ,fungi ,Gastroenterology ,Cancer ,Anus Neoplasms ,medicine.disease ,eye diseases ,Surgery ,Radiation therapy ,medicine.anatomical_structure ,Female ,Radiology ,Presentation (obstetrics) ,business - Abstract
We report a case of anal cancer with iris metastasis and summarize the iris metastasis literature. A 69 years old woman with a history of anal cancer presented with a visual field loss. Slit lamp examination showed a pink ovular mass on the iris of the left eye which was typical of iris metastasis. Because of worse prognosis of metastatic cancer and any ocular complications, the patient was treated by radiotherapy which allowed a clinical improvement. A review of medical records was performed to assess the clinical presentation, diagnosis and treatment. Anal carcinoma can metastasize to the iris. Radiotherapy allows a good local control of tumour but the prognosis depends on systemic disease which is generally bad.
- Published
- 2009
22. Unusual skeletal muscle metastasis from gastric adenocarcinoma
- Author
-
F. Dujardin, H. Hamidou, David Tougeron, Pierre Michel, F. Di Fiore, and C. Maillard
- Subjects
Male ,Shoulder ,medicine.medical_specialty ,Adenocarcinoma ,Metastasis ,Gastric adenocarcinoma ,Stomach Neoplasms ,Deltoid muscle ,Biopsy ,medicine ,Humans ,Stomach cancer ,Aged ,Muscle Neoplasms ,medicine.diagnostic_test ,business.industry ,Gastroenterology ,Cancer ,Skeletal muscle ,General Medicine ,medicine.disease ,Surgery ,medicine.anatomical_structure ,Radiology ,business ,Chemoradiotherapy - Abstract
Patients with gastric adenocarcinoma frequently develop hepatic metastases or peritoneal carcinosis but involvement of the skeletal muscle is extremely rare. We report the case of a 71-year-old man with a painful soft tissue mass in the right shoulder. Two years previously, the patient had been treated for a locally advanced gastric carcinoma (surgery plus chemoradiotherapy). Surgical exploration with biopsy showed skeletal muscle metastasis from the gastric adenocarcinoma in the deltoid muscle. Chemoradiotherapy resulted in complete regression of symptoms from the metastatic lesion. The patient is alive and free of recurrence in the deltoid muscle after a follow-up of 13 months. Based on this case study, the difficulty of diagnosing skeletal muscle metastases, the prognosis and treatment options are discussed.
- Published
- 2009
23. Safety and outcome of chemoradiotherapy in elderly patients with rectal cancer: results from two French tertiary centres
- Author
-
Bernard Roullet, Pierre Michel, H. Hamidou, René-Jean Bensadoun, Jean-Marc Tourani, Christine Silvain, Bernard Paillot, and David Tougeron
- Subjects
Male ,medicine.medical_specialty ,Organoplatinum Compounds ,Colorectal cancer ,Leucovorin ,Antineoplastic Agents ,Kaplan-Meier Estimate ,Deoxycytidine ,Disease-Free Survival ,Capecitabine ,Internal medicine ,medicine ,Humans ,Neoplasm Metastasis ,Adverse effect ,Survival rate ,Aged ,Neoplasm Staging ,Retrospective Studies ,Tegafur ,Aged, 80 and over ,Hepatology ,business.industry ,Rectal Neoplasms ,Gastroenterology ,Retrospective cohort study ,Chemoradiotherapy, Adjuvant ,medicine.disease ,Oxaliplatin ,Discontinuation ,Surgery ,Vitamin B Complex ,Female ,Fluorouracil ,France ,business ,Chemoradiotherapy ,medicine.drug - Abstract
Background The risks of chemoradiotherapy in elderly patients with rectal cancer have not yet been well-characterised. Methods We retrospectively reviewed the charts of patients with rectal cancer over 70 years old who were treated with chemoradiotherapy in two French university hospitals. Results A total of 125 patients were evaluated. Mean age was 75.1 ± 4.1 years and ranged from 70 to 90 years. Adverse effects ≥ grade 2 were observed in 32% of the patients and adverse effects ≥ grade 3 in 15%. Dose reduction for toxicity was performed in 18% of the patients and chemoradiotherapy discontinuation was necessary in 9%. Postoperative morbidity was 16% with two treatment-related deaths. Two-year survival rate was 84%. No variables had any influence on treatment-related adverse events. Conclusions In selected elderly patients, chemoradiotherapy is well-tolerated, without any significant increase in adverse events, and the results are similar to those recorded in younger patients.
- Published
- 2011
24. Definitive chemoradiotherapy in patients with esophageal adenocarcinoma: an alternative to surgery?
- Author
-
Pierre Michel, H. Hamidou, Francis Michot, F. Di Fiore, David Tougeron, Michel Scotté, and Bernard Paillot
- Subjects
Male ,medicine.medical_specialty ,genetic structures ,Esophageal Neoplasms ,Locally advanced ,Esophageal adenocarcinoma ,Adenocarcinoma ,Complete resection ,Weight loss ,Antineoplastic Combined Chemotherapy Protocols ,medicine ,Humans ,In patient ,Stage (cooking) ,Aged ,Neoplasm Staging ,Retrospective Studies ,Performance status ,business.industry ,General Medicine ,Definitive chemoradiotherapy ,Middle Aged ,Prognosis ,Combined Modality Therapy ,Surgery ,Survival Rate ,Oncology ,Lymphatic Metastasis ,Female ,Fluorouracil ,medicine.symptom ,Cisplatin ,Neoplasm Recurrence, Local ,business ,Follow-Up Studies - Abstract
Background and Objectives Definitive chemoradiotherapy (CRT) is considered curative intent treatment for locally advanced esophageal squamous cell carcinoma. Data concerning the usefulness of definitive CRT in patients with esophageal adenocarcinoma (ADC) are lacking. The aim of the study was to compare the results of definitive CRT versus surgery in patients with an ADC. Methods All consecutive patients with a non-metastatic ADC treated between 1994 and 2008 were retrospectively assessed. Patients were divided into two groups: surgery group (±pre-operative treatment) versus definitive CRT group. Results In surgery and definitive CRT groups, 67 and 79 patients were evaluated, respectively. A complete resection was achieved in 92.5% of patients in surgery group and a clinical complete response was observed in 49.4% of patients in definitive CRT group. Overall survival was 36.2 ± 2.0 months in surgery group versus 16.5 ± 0.8 months in definitive CRT group (P = 0.02). The predictive factors of survival were age (P
- Published
- 2011
25. Basaloid squamous cell carcinoma of the head and neck: report of 18 cases
- Author
-
A François, H. Hamidou, M. Bertrand, Danièle Dehesdin, Emmanuel Blot, and O. Choussy
- Subjects
Larynx ,Male ,Pathology ,medicine.medical_specialty ,medicine.medical_treatment ,Kaplan-Meier Estimate ,Diagnosis, Differential ,Carcinoma, Basosquamous ,Risk Factors ,medicine ,Carcinoma ,Humans ,Basal cell carcinoma ,Neoplasm Metastasis ,Basaloid Squamous Cell Carcinoma ,Survival rate ,Aged ,Neoplasm Staging ,Retrospective Studies ,Aged, 80 and over ,Staining and Labeling ,business.industry ,General Medicine ,Middle Aged ,medicine.disease ,Head and neck squamous-cell carcinoma ,Combined Modality Therapy ,Immunohistochemistry ,Radiation therapy ,Survival Rate ,medicine.anatomical_structure ,Otorhinolaryngology ,Epidermoid carcinoma ,Head and Neck Neoplasms ,Disease Progression ,Female ,business - Abstract
Objective:To evaluate the clinical course and pathological characteristics of basaloid head and neck squamous cell carcinoma.Method:Retrospective study of 18 cases of basaloid head and neck squamous cell carcinoma. Epidemiological, clinical and histological data were analysed and the Kaplan–Meier test used to estimate survival rates.Results:The majority of lesions were at an advanced stage. These lesions were primarily localised in the larynx, hypopharynx and oropharynx. Routine pre-therapeutic assessment of squamous cell carcinoma was performed. Pathological diagnosis was difficult, although immunostaining was extremely useful. Positive staining for KL1, MNF 116 and 34βE12 and negative immunostaining for chromogranin and synaptophysin were also important factors in obtaining a definitive diagnosis. In the majority of cases, treatment involved surgery and radiotherapy. The five-year survival rate was 5 per cent.Conclusion:Basaloid squamous cell carcinoma is an uncommon head and neck lesion, with a challenging histological diagnosis. These lesions must be carefully monitored due to their aggressive course, and require multimodality treatment.
- Published
- 2011
26. Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancer
- Author
-
David Tougeron, F. Di Fiore, I. Iwanicki-Caron, N. Berbera, H. Hamidou, Pierre Michel, Bernard Paillot, and Sébastien Thureau
- Subjects
Male ,Cancer Research ,medicine.medical_specialty ,oesophageal cancer ,Esophageal Neoplasms ,medicine.medical_treatment ,Antineoplastic Agents ,Adenocarcinoma ,definitive chemoradiotherapy ,elderly patients ,Gastroenterology ,Internal medicine ,health services administration ,Clinical Studies ,medicine ,Carcinoma ,Humans ,Adverse effect ,Survival analysis ,Aged ,Aged, 80 and over ,Chemotherapy ,business.industry ,Cancer ,medicine.disease ,Survival Analysis ,Discontinuation ,Surgery ,Radiation therapy ,Treatment Outcome ,Oncology ,Carcinoma, Squamous Cell ,Female ,Cisplatin ,business ,Chemoradiotherapy - Abstract
Little is known about chemoradiotherapy (CRT) in elderly patients with a locally advanced oesophageal cancer (OC). The aim of our study was to evaluate the tolerance and the outcome of elderly patients older than 70 years treated with CRT for a non-metastatic OC. Chemoradiotherapy was based on radiotherapy combined with a cisplatin-based chemotherapy. Clinical complete response (CCR) to CRT was evaluated on upper digestive endoscopy and computed tomography scan 6-8 weeks after CRT completion. One hundred and nine consecutive patients were included. A CCR was observed in 63 patients (57.8%) and 2-year survival was 35.5%. Adverse eventsor =grade 3 were observed in 26 (23.8%) patients. Chemotherapy dose reduction, chemotherapy delays more than 1 week, and treatment discontinuation were observed in 33 (30.3%), 45 (41.3%), and 17 patients (15.6%), respectively. Comorbidity index according to Charlson score was significantly associated with treatment tolerance. In multivariate analysis, a CCR to CRT (P0.01), a dose of radiotherapyor =80% (P=0.02), and a Charlson scoreor =2 (P=0.046) were identified as independent prognostic factors of overall survival. These results suggest that CRT could be considered as an effective treatment without major toxicity in elderly patients with OC.
- Published
- 2008
27. Response to definitive chemoradiotherapy and survival in patients with an oesophageal adenocarcinoma versus squamous cell carcinoma: a matched-pair analysis
- Author
-
Olivier Rigal, H. Hamidou, Pierre Michel, David Tougeron, Frédéric Di Fiore, and Bernard Paillot
- Subjects
Oncology ,Adult ,Male ,Cancer Research ,medicine.medical_specialty ,genetic structures ,Esophageal Neoplasms ,Adenocarcinoma ,Gastroenterology ,Internal medicine ,Carcinoma ,medicine ,Combined Modality Therapy ,Humans ,Survival analysis ,Aged ,Retrospective Studies ,Aged, 80 and over ,business.industry ,Esophageal disease ,Incidence ,Smoking ,Cancer ,Retrospective cohort study ,General Medicine ,Middle Aged ,medicine.disease ,Prognosis ,Survival Analysis ,Treatment Outcome ,Carcinoma, Squamous Cell ,Female ,France ,business ,Deglutition Disorders ,Chemoradiotherapy - Abstract
Objectives: The impact of the histological tumour type in patients treated with definitive chemoradiotherapy (CRT) for an oesophageal cancer is not well established. The aim of this retrospective matched-pair analysis was to evaluate the clinical complete response (CCR) to definitive CRT and the outcome between 2 groups of patients. Methods: Fifty-seven patients with an oesophageal adenocarcinoma (ADC) were matched according to the tumour stage and the WHO performance as well as the CRT regimen status including 57 patients with an oesophageal squamous cell carcinoma (SCC). CRT was based on radiotherapy combined with a cisplatin-based chemotherapy. Results: A CCR was observed in 40 patients (70.2%) with an SCC as compared with 26 patients (45.6%) with an ADC (p = 0.013). SCC patients received significantly more of planned cisplatin and radiotherapy doses than ADC patients (82.0 vs. 67.7%, p = 0.042, and 92.5 vs. 84.5%, p = 0.023, respectively). In responders to CRT, local recurrence was significantly more frequent in SCC patients (52.5 vs. 26.9%, p = 0.046). Median survival in all patients as well as in responders to CRT was not different between the 2 groups. Conclusion: Our study showed that treatment completion and CCR to definitive CRT were more frequent in SCC with, however, more local recurrences in these patients. Further studies are required to confirm this difference in response rate to definitive CRT according to histological type of the tumour in oesophageal cancer.
- Published
- 2007
28. Baseline nutritional status is predictive of response to treatment and survival in patients treated by definitive chemoradiotherapy for a locally advanced esophageal cancer
- Author
-
H. Hamidou, Philippe Ducrotté, Pierre Michel, Bernard Paillot, Daniela Pop, Frédéric Di Fiore, Eric Lerebours, Stéphane Lecleire, and Olivier Rigal
- Subjects
Oncology ,Male ,medicine.medical_specialty ,Esophageal Neoplasms ,medicine.medical_treatment ,Nutritional Status ,Statistics, Nonparametric ,Predictive Value of Tests ,Risk Factors ,Internal medicine ,medicine ,Humans ,Survival analysis ,Neoplasm Staging ,Proportional Hazards Models ,Retrospective Studies ,Chi-Square Distribution ,Hepatology ,Proportional hazards model ,business.industry ,Esophageal disease ,Gastroenterology ,Retrospective cohort study ,Radiotherapy Dosage ,Esophageal cancer ,Middle Aged ,medicine.disease ,Survival Analysis ,Surgery ,Radiation therapy ,Logistic Models ,Treatment Outcome ,Predictive value of tests ,Female ,Cisplatin ,business ,Deglutition Disorders ,Chemoradiotherapy - Abstract
To assess the impact of baseline nutritional status on treatment response and survival in nonmetastatic patients with a locally advanced esophageal cancer (LAEC) treated with definitive chemoradiotherapy (CRT).One hundred five patients with LAEC treated by definitive CRT were retrospectively included. The CRT regimen was based on an external radiotherapy (RT) delivered concomitantly to a cisplatin-based chemotherapy (CT). Patients were considered to have a complete response (CR) to CRT when no residual tumor was detected on CT scan and esophagoscopy performed 2 months after the end of CRT. Multivariate analysis of predictive factors of response to CRT and survival were performed using a logistic regression and a Cox model, respectively.Mean value of baseline nutritional parameters was significantly different between nonresponder (N = 42) and responder (N = 63) patients to CRT (weight loss 10%vs 5.8%, P= 0.0047; serum albumin level 35 g/L vs 38.7 g/L, P= 0.0004; BMI 22.8 kg/m2vs 25.2 kg/m2, P= 0.01). In multivariate analysis, serum albumin level35 g/L was the only independent predictive factor of CR to CRT (P= 0.009). Independent prognostic factors of survival were BMI18 kg/m2 (P= 0.003), dysphagia Atkinson score2 (P= 0.008), dose of RT50 Grays (Gy) (P0.0001) and CR to CRT (P0.0001).Survival was influenced by baseline nutritional status as well as dysphagia, dose of RT, and CR to CRT. Despite the retrospective design of the study, our results may provide the concept basis for performing a prospective nutritional intervention study in patients treated by definitive CRT for an esophageal cancer.
- Published
- 2007
29. Radiothérapie hypofractionnée à fortes doses de métastases osseuses vertébrales non compressives en association avec l’acide zolédronique : étude de phase 1 multicentrique et prospective
- Author
-
B. Pichon, C. Laude, F. Thillays, P. Pommier, Gregory Delpon, Marc-André Mahé, Christian Carrie, H. Hamidou, P. Cellier, and A. Mervoyer
- Subjects
Oncology ,Radiology, Nuclear Medicine and imaging - Abstract
Objectifs La radiotherapie hypofractionnee stereotaxique des metastases vertebrales est tres efficace, mais augmente le risque fracturaire dans le volume traite. Des etudes precliniques et cliniques ont demontre que l’acide zoledronique reduisait ce risque fracturaire, activait le remodelage osseux et augmentait la reponse immunitaire et la radiosensibilite. Cette etude visait a evaluer la tolerance de l’acide zoledronique associe a la radiotherapie. Materiel et methodes Nous avons mene une etude multicentrique sur la delivrance conjointe d’une radiotherapie hypofractionnee stereotaxique de trois fractions de 9 Gy dans 90 % de la dose prescrite dans 90 % du volume cible previsionnel et d’acide zoledronique a raison de 12 injections mensuelles chez des patients atteints de metastases vertebrales (NCT01219790). Les criteres d’inclusion etaient la presence de metastase vertebrale avec une distance minimale de 5 mm entre le volume tumoral macroscopique et moelle epiniere, et une clairance de la creatinine de plus de 30 mL/min. Les criteres d’exclusion etaient un antecedent d’irradiation de la metastase vertebrale ou une symptomatologie neurologique. Les volumes traites ont ete definis selon le consensus international de radiochirurgie. L’objectif principal etait l’absence de toxicite medullaire a un an. Les objectifs secondaires etaient la tolerance aigue, le controle antalgique et local, la survenue d’evenements osseux et la survie globale. Resultats Trente patients, 25 hommes et cinq femmes, suivis en mediane 376j ont ete pris en charge pour 49 metastases vertebrales, huit cervicales, 19 thoraciques, 19 lombaires, et trois sacrees, secondaires a des cancers de la prostate (17), du rein (trois), du sein (trois), du poumon (trois), du colon–rectum (deux), et de sarcomes (deux). Les metastases vertebrales ont ete traitees par CyberKnife® (six), Tomotherapy® (18), Novalis® (20) ou Clinac® (cinq). Une toxicite aigue muqueuse de grade 3 ou plus a ete notee chez deux patients (le volume cible previsionnel depassait 170 cm3). Il n’y a eu aucune toxicite neurologique a un an mais une nevralgie cervicobrachiale a 6 mois resolutive. La douleur, mesuree par echelle visuelle numerique, a diminue, passant d’un score moyen de 1,43 a 1 mois et 0,96 a 3 mois, par rapport a l’inclusion (2,51). Un tassement vertebral a ete decrit chez deux patients. Le taux de controle local etait de 93,9 %, avec trois recidives locales. Conclusion La delivrance conjointe d’acide zoledronique et de radiotherapie hypofractionnee stereotaxique pour des metastases vertebrales est bien toleree mais peut augmenter la toxicite muqueuse aigue en cas de volume irradie important. Les resultats sont prometteurs a moyen terme avec une excellente efficacite, sans toxicite neurologique a un an.
- Published
- 2015
30. A comparison between Raman spectroscopy and surface characterizations of multiwall carbon nanotubes
- Author
-
M. Trinquecoste, J. Dentzer, Cathie Vix-Guterl, H. Hamidou, Michel Couzi, P. Delhaes, Centre de recherches Paul Pascal (CRPP), Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS), Laboratoire de Physico-Chimie Macromoléculaire (UMR 7615) (LPCM), Université Pierre et Marie Curie - Paris 6 (UPMC)-Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI Paris), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Centre National de la Recherche Scientifique (CNRS), Institut de chimie des surfaces et interfaces de Mulhouse (ICSIM), Ecole Nationale Supérieure de Chimie de Mulhouse-Centre National de la Recherche Scientifique (CNRS), Institut de Chimie et des Surfaces et Interfaces (ICSI), and Université de Haute-Alsace (UHA) Mulhouse - Colmar (Université de Haute-Alsace (UHA))-Centre National de la Recherche Scientifique (CNRS)
- Subjects
Materials science ,Carbons nanotubes ,Mechanical properties of carbon nanotubes ,02 engineering and technology ,Carbon nanotube ,010402 general chemistry ,01 natural sciences ,law.invention ,symbols.namesake ,Surface area ,law ,General Materials Science ,Composite material ,Graphene ,General Chemistry ,021001 nanoscience & nanotechnology ,0104 chemical sciences ,Coherence length ,Optical properties of carbon nanotubes ,[CHIM.THEO]Chemical Sciences/Theoretical and/or physical chemistry ,Chemical physics ,Raman spectroscopy ,symbols ,surface properties ,0210 nano-technology ,Coherence (physics) - Abstract
The distribution of graphene units with an axial symmetry gives rise to different types of carbon filaments: nanotubes, nanofilaments and classical fibers. In this work the surfaces of different multiwalled nanotubes are characteirzed by two complementary techniques: chemical ones based on Total Surface Area and Active Surface Area measurements, associated with a physical approach the Raman scattering spectroscopy. From analysis of Raman data we deduce the values of the in-plane coherence lengths, identified as L1 the planar projection of gaphene sheets, and we propose an analysis for the observed line-width bahavior related to the graphitation step. From coherence length L1 for all types of MWNT. This analysis allows us to show the influence of both, the structural organization and the different treatments on the interfacial characteristics of these nanocarbons.
- Published
- 2006
31. UFT (Tégafur®)–radiothérapie: unealternative àlachimioradiothérapie adjuvante classique chezlespatients opérés d'un cancer del'estomac etd'un cancer dupancréas
- Author
-
Sébastien Thureau, T. Babba, Bernard Paillot, F. Di Fiore, H. Hamidou, and Pierre Michel
- Subjects
Oncology ,business.industry ,Medicine ,Radiology, Nuclear Medicine and imaging ,business - Published
- 2007
32. Subject Index Vol. 73, 2007
- Author
-
Serena Sestini, W.G. Jiang, Hideo Akiyama, Maurie Markman, M. Emin Kalender, Kohkichi Hata, Rosangela Romano, M. Basaran, Martin Stuschke, Satoshi Shiojima, Anastassios V. Koutsopoulos, Ibrahim Sari, Zong-guang Zhou, Georgia Karpathiou, M.M. Javle, Christelle De La Fouchardiere, Nikos Antoniou, Jie Zhang, Olivier Rigal, Yavuz Pehlivan, Atsushi Itami, Naofumi Nagasue, Wang Jinhui, N.F. Aykan, Michael Chrisofos, Hitoshi Matsumoto, Wilfried Eberhardt, H. Hamidou, Giulia Lo Russo, R.J. Menezes, Chen Huixin, A. Douglas-Jones, A. Scharl, Helmut Teschler, Romain Coriat, G.Y. Yang, Toshinao Onoda, N. Guney, G. Morack, Gozoh Tsujimoto, Torello Lotti, J. Robson, Li Xiaoyan, J. Alkhaddo, Go Watanabe, Yu-jian Zeng, A.K. Dixon, G. Watkins, Yutaka Shimada, Motoshige Higashiyama, S. Maddipatla, Shiori Tomoda, Ulrich Abel, Eiji Tanaka, Sabine Levegruen, Frédéric Di Fiore, Thomas Krbek, Andreas Skolarikos, Domenico Germano, George Lainakis, Gilberto Schwartsmann, Xiao-Feng Sun, Mehmet Emin Kalender, Tadashi Kadowaki, Si Young Song, A. Argon, Hideyuki Ohnuma, Tatsuya Yamagata, Yasuhito Tonomoto, Alper Sevinc, M. Stauch, Ling Wang, Jiang Zhu, Yuan Li, S.R. Davies, Bai Aiping, Sung Ho Choi, Daniela Baumann Cornelio, Genny Leporatti, A. Rani, U. Vehling-Kaiser, Takatsugu Kan, Yasuhiro Ito, C. Poettgen, Dirk Theegarten, Song Xin, B. Kalischefski, Christina Herrmann, Sylvie Negrier, Mei Hou, Pierre Michel, Bülent Akgul, D. Laessig, Dipok Kumar Dhar, Fumiaki Sato, C.M. Levea, Wolfgang Stremmel, F. Eid, Dirk Jaeger, A.U. Pande, Bin Zhou, Meletios A. Dimopoulos, Woo Jin Hyung, Aristotle Bamias, David Tougeron, D. Mazhar, Hiroshi Yoshida, Bernard Paillot, Luise Meurer, Wong Benjamin Chun Yu, Gazi Comez, H.J. Stemmler, S. Saglam, A. Chhabra, Olivia Diaz, Jeong Youp Park, Evangelia Argiana, Akira Myoumoto, Bing Xu, Thomas Gauler, Hitoshi Nobumasa, Xiaoyan Yang, Tetsuo Ito, M.V. Williams, S. Raj, Toshinori Sato, Luigi Manzione, Mario Dini, H. Mehmet Turk, Jorge Filmus, Chen Minhu, Peixing Wu, Michihide Mitsumori, Z. Ustuner, Katsuhisa Noda, Françoise Desseigne, Jun-min Song, Mariana Capurro, Shen Benchang, Andreas Bockisch, Stephen J. Meltzer, G. Loewen, M.E. Reid, N. Natarajan, R.V. Iyer, Mitsuo Tachibana, Seungmin Bang, Lie Yang, Kanako Yamanaka, H. Kölbl, P. Maubach, Akira Miyauchi, C.E. Nwogu, M.A. Ustaoglu, A.N. Tenekeci, M. Gumus, V. Heinemann, Eiji Miyoshi, B. Weber, Noriko Okuyama, B. Sakar, Shinichi Miyamoto, N. Ramnath, Yan Wang, Shigemi Matsumoto, Rafael Roesler, Sung Hoon Noh, Hui Yan Li, Pu Wang, H. Meerpohl, Daniela Massi, J.D. Black, Georgios Stamatis, Marios Froudarakis, Andreas Koureas, Celalettin Camci, G. Alivizatos, P. Dua, Sadako Yamagata, Thomas R. W. Herrmann, Jinghai Zhang, Vincenzo De Giorgi, Yong Soo Kim, Hilmar Kuehl, Efstathios Kastritis, Evangelos Karayiotis, F. Melchert, Hai-yi Liu, G. Paganelli, R.E. Mansel, Metin Karakok, P.A. Fasching, H. Kynaston, Hong-zhi Luo, H.S. Fernando, and Tsuneo Tanaka
- Subjects
Cancer Research ,Index (economics) ,Oncology ,Statistics ,Subject (documents) ,General Medicine ,Mathematics - Published
- 2007
33. Prognostic value of the expression of tumor necrosis factor-alpha (TNFa) and its receptors in head and neck cancer (HNC) patients: A pilot study
- Author
-
Arnaud François, S. Laberge-Le Couteulx, Jean-Michel Picquenot, Isabelle Tennevet, Emmanuel Blot, H. Hamidou, Florian Clatot, Marie Cornic, L. Hong, and Olivier Choussy
- Subjects
Cancer Research ,Pathology ,medicine.medical_specialty ,business.industry ,Head and neck cancer ,medicine.disease ,In vitro ,Oncology ,Apoptosis ,Cancer cell ,medicine ,Cancer research ,Tumor necrosis factor alpha ,business ,Receptor - Abstract
e17029 Background: TNFa was initially described as an inductor of apoptosis in cancer cells. In vitro data showed that TNFa can also activate anti-apoptotic signaling in cancer cells. We analyzed the prognostic value of the expression of TNFa and its receptors TNFR1 and TNFR2 in HNC patients. Methods: Twenty-four patients treated for HNC were retrospectively analyzed for TNFa, TNFR1, and TNFR2 expression by real-time PCR (RT-PCR). Tissue samples were collected at the time of initial diagnosis. Total RNA was reverse-transcribed with TaqMan quantitative RT-PCR (Applied Biosystems). Results were recorded as average threshold cycle, and relative expression was determined using Normalized Expressions method. Expression of TNFa, TNFR1, and TNFR2 was related to survival after 3 years of follow-up. Results: In the 24 patients, expression of TNFa (mean value 7.8, median 2.4, range 0.02–62.3), TNFR1 (mean value 58, median 49, range 0.02–246.9) and TNFR2 (mean value 4.8, median 3.3, range 0.8–18.9) demonstrated a great variability between patients. After a 3-year follow-up, 14 patients were alive without evolution of cancer (group A) and 10 were dead because of cancer evolution (group D). In group D, median level of TNFa was 8.8 whereas it was 1.1 in group A (p = 0.02). Median level of TNFR1 was 71.8 in group D and 28.5 in group A (p = 0.01). In contrast, median level of TNFR2 was 3.3 for both groups. Patients with high level of TNFa or TNFR1 expression had a worse survival (p = 0.01 and p = 0.009, respectively). There was also a strong correlation between high expression of TNFa and of TNFR1 (p = 0.0007). Conclusions: In this small series, TNFa and TNFR1 expression seem to have significant prognostic value to predict survival of HNC patients. This result needs to be confirmed in larger series and compared with usual prognostic factor. It suggests that TNFa expression could have a dual effect in HNC and that TNFR1 expression may play a role in this process. No significant financial relationships to disclose.
- Published
- 2009
34. P.180 Prise en charge thérapeutique des cancers de l’œsophage chez le sujet âgé
- Author
-
N. Berbera, Sébastien Thureau, I. Iwanicki-Caron, David Tougeron, H. Hamidou, Pierre Michel, M. Steitu, Bernard Paillot, and F. Di Fiore
- Subjects
Gynecology ,medicine.medical_specialty ,business.industry ,Gastroenterology ,medicine ,General Medicine ,business - Abstract
Introduction Il existe peu de donnees sur la strategie therapeutique des cancers de l’œsophage (CO) chez le patient âge. Le but de cette etude est de decrire la prise en charge therapeutique et l’evolution de ces patients dans notre institution. Patients et Methodes Tous les patients de plus de 70 ans avec un CO, suivis entre 1994 et 2007, ont ete retrospectivement analyses. Les patients ont ete divises en 3 groupes : traitement a visee curative (CO sans metastase viscerale traites par radiochimiotherapie (RCT), chirurgie, radiotherapie, mucosectomie ou phototherapie dynamique), traitement a visee palliative (CO avec metastase(s) viscerale(s) traites par chimiotherapie (CT), RCT ou radiotherapie) ou soins symptomatiques (prothese œsophagienne ou abstention therapeutique). Les facteurs influencant le traitement et la survie ont ete recherches. Resultats Il a ete analyse 282 patients avec une moyenne d’âge de 76,5 ans (70 - 96 ans). La prevalence d’une comorbidite selon le score de Charlson etait de 30,7 % et 60,8 % des patients avaient un indice de performance OMS a 0 ou 1. La majorite des CO etait de type epidermoide (67,5 %) et 25,3 % des patients avaient une tumeur stade IV. Cent cinquante et un patients (53,5 %) ont beneficie d’un traitement a visee curative (majoritairement par RCT, n = 111), 35 patients (12,4 %) d’un traitement palliatif (majoritairement par CT, n = 22) et 96 patients (34,0 %) de soins symptomatiques. Parmi les patients stade M0 ou M1a (n = 215), la majorite a recu un traitement a visee curative (n = 151, 70,2 %) mais parmi les patients avec une tumeur M1b (n = 62), la majorite a recu exclusivement des soins symptomatiques (n = 33). Des effets secondaires severes (≥ grade 3) lies au traitement etaient observes chez 17 % des patients. Les patients avec un traitement carcinologique etaient significativement plus jeunes (p Conclusion Cette premiere etude sur une large population de patients âges atteints d’un CO suggere que la realisation d’un traitement carcinologique est envisageable apres selection des patients en fonction des facteurs pronostiques et des comorbidites.
- Published
- 2009
35. 649Orbital metastasis: Radiation therapy results (w/wo chemotherapy)
- Author
-
M. Benmiloud, Michel Schlienger, F. Pene, Laurent Schwartz, Martin Housset, H. Hamidou, and Emmanuel Touboul
- Subjects
Oncology ,Chemotherapy ,medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Hematology ,medicine.disease ,Metastasis ,Radiation therapy ,Internal medicine ,medicine ,Radiology, Nuclear Medicine and imaging ,business - Published
- 1996
36. 540Proliferation indexes: An in vitro and in vivo comparative study in golden syrian hamster's pancreatic adenocarcinoma
- Author
-
R. Petroni, C. Elie, J.G. Rateau, M. Benmiloud, J.F. Bernaudin, H. Hamidou, and F. Lecaine
- Subjects
medicine.medical_specialty ,Hamster ,Hematology ,Biology ,medicine.disease ,In vitro ,Endocrinology ,Oncology ,In vivo ,Internal medicine ,Cancer research ,medicine ,Adenocarcinoma ,Radiology, Nuclear Medicine and imaging - Published
- 1996
37. 728Acoustic neurinomas linac stereotactic radiosurgery: Preliminary results
- Author
-
H. Hamidou, T. Hancilar, D. Lefkopoulos, Emmanuel Touboul, M. Benmiloud, Michel Schlienger, and L. Merienne
- Subjects
Oncology ,business.industry ,medicine.medical_treatment ,medicine ,Radiology, Nuclear Medicine and imaging ,Hematology ,business ,Nuclear medicine ,Radiosurgery ,Linear particle accelerator - Published
- 1996
38. 531Is pancreatic adenocarcinoma radiosensitive? Preliminary results in vitro with a golden syrian hamster's pancreatic adenocarcinoma cell line
- Author
-
M. Benmiloud, H. Hamidou, Emmanuel Touboul, J.F. Bernaudin, and J.G. Rateau
- Subjects
Oncology ,medicine.medical_specialty ,business.industry ,Adenocarcinoma cell ,Hamster ,Hematology ,medicine.disease ,In vitro ,Internal medicine ,medicine ,Cancer research ,Adenocarcinoma ,Radiology, Nuclear Medicine and imaging ,Line (text file) ,business - Published
- 1996
39. 440 Oral tongue cancer: Long-term results with radiation therapy
- Author
-
F. Pene, Emmanuel Touboul, M. Benmiloud, A. Laugier, Michel Schlienger, and H. Hamidou
- Subjects
Cancer Research ,Chemotherapy ,medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Brachytherapy ,Cancer ,Neck dissection ,Long term results ,medicine.disease ,Metastasis ,Surgery ,Radiation therapy ,medicine.anatomical_structure ,Oncology ,Tongue ,medicine ,Radiology ,business - Abstract
Background Even with the advent of neoadjuvant chemotherapy or concomitant chemoradiotherapy, little progress has been made in therapy of oral tongue cancer. So it could be interesting to reassess definitive radiation therapy value in this pathology. Purpose Evaluate our long-term results in oral tongue cancer. Materials and methods Fourty-four patients with epidermoid oral tongue cancer were successively treated in our department from 1972 to 1979. There were 38 men, 6 women. Age ranged from 43 to 78 (mean 60). There were 17 T1, 20 T2, 7 T3 and 5 Np. They were treated with brachytherapy (24 cases) or radiation therapy + brachytherapy (20 cases) on their primary. Radical neck dissection was conducted before or after treatment of the primary in 22 cases. Endpoints were local control, metastasis, second primaries, survival and tolerance of treatment. Conclusion Despite a good local control with radiation therapy, distant metastasis and second primaries result in a very low survival. Alternative therapies (as retinoids?) are still awaited in this bad prognosis alcoholism and tobacco use induced pathology.
- Published
- 1995
40. [Elephantiasis and oseous malformations limited to the buttock and right thigh in von Recklinghausen's neurofibromatosis]
- Author
-
N, Kuhlmann, H, Hamidou, F, Renaud, and H, François
- Subjects
Male ,Neurofibromatosis 1 ,Humans ,Lymphedema ,Bone Diseases ,Middle Aged - Published
- 1965
41. Esophageal cancer in the elderly: an analysis of the factors associated with treatment decisions and outcomes
- Author
-
Pierre Michel, David Tougeron, Michel Antonietti, Frédéric Di Fiore, Michel Scotté, Bernard Paillot, and H. Hamidou
- Subjects
Male ,Cancer Research ,medicine.medical_specialty ,Palliative care ,Esophageal Neoplasms ,MEDLINE ,Antineoplastic Agents ,Medical Oncology ,lcsh:RC254-282 ,Surgical oncology ,Genetics ,medicine ,Humans ,Neoplasm Metastasis ,Intensive care medicine ,Aged ,Retrospective Studies ,Aged, 80 and over ,Geriatrics ,Models, Statistical ,business.industry ,Palliative Care ,Cancer ,Retrospective cohort study ,Middle Aged ,Esophageal cancer ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,medicine.disease ,Treatment Outcome ,Oncology ,Physical therapy ,Female ,Treatment decision making ,business ,Research Article - Abstract
Background Only limited data has been reported so far regarding oesophageal cancer (EC) in elderly patients. The aim of the study is to identify the baseline parameters that influenced therapeutic decision. Methods All consecutive patients 70 years or older being treated for EC were retrospectively analyzed. Patients without visceral metastasis were divided into two groups: treatment with curative intent (chemoradiotherapy, surgery, radiotherapy, mucosectomy or photodynamic therapy) or best supportive care (BSC). Patients with metastasis were divided into two groups: palliative treatment (chemotherapy, chemoradiotherapy or radiotherapy) or BSC. Results Two hundred and eighty-two patients were studied. Mean age was 76.5 ± 5.5 years and 22.4% of patients had visceral metastasis. In patients without visceral metastasis (n = 220) the majority had treatment with curative intent (n = 151) whereas in patients with metastasis (n = 62) the majority had BSC (n = 32). Severe adverse events (≥ grade 3) were observed in only 17% of the patients. Patients without specific carcinologic treatment were older, had more weight loss, worse WHO performance status and Charlson score in multivariate analysis. Discussion Our results suggest that elderly patients with an EC could benefit from cancer treatment without major toxicities. Weight loss, WHO performance status and the Charlson score could be used to select the appropriate treatment in an elderly patient.
42. EP-1067: Non metastatic esophagus cancer: outcome according to therapeutic strategy
- Author
-
N. Mesgouez-Nebout, S. Giraud, P. Cellier, Amaury Paumier, D. Rousseau, H. Hamidou, and O. Capitain
- Subjects
Oncology ,medicine.medical_specialty ,business.industry ,Cancer ,Hematology ,medicine.disease ,Outcome (game theory) ,medicine.anatomical_structure ,Radiology Nuclear Medicine and imaging ,Internal medicine ,medicine ,Non metastatic ,Radiology, Nuclear Medicine and imaging ,Esophagus ,business ,Therapeutic strategy - Full Text
- View/download PDF
43. Brain radiotherapy in patients treated for a newly diagnosed primary central nervous system lymphoma: professional practice evaluation in 19 French centers.
- Author
-
Thomas-Joulié A, Houillier C, Antoni D, Créhange G, Jouglar E, Colin P, Benchalal M, Lang P, Alfonsi M, Hamidou H, Coutte A, Ahrweiller F, Dadoun N, Pointreau Y, Ammarguellat H, Bernier-Chastagner V, Belkacemi Y, Vieillot S, Hoang-Xuan K, Soussain C, Jacob J, and Feuvret L
- Subjects
- Humans, Retrospective Studies, Brain pathology, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Methotrexate, Combined Modality Therapy, Central Nervous System Neoplasms radiotherapy, Lymphoma radiotherapy, Lymphoma pathology
- Abstract
Introduction: The objective of this study was a multicentric evaluation of professional practices, analyzing the irradiation technique itself and its impact on survival and recurrence sites, in primary central nervous system lymphomas (PCNSLs)., Methods: We retrospectively analyzed the technical and clinical records of 79 PCNSL patients included in the database of the national expert network for oculocerebral lymphoma ('LOC') who were treated with brain radiotherapy as first-line treatment for newly diagnosed primary central nervous system lymphoma between 2011 and 2018., Results: The number of patients treated with brain radiotherapy gradually decreased over time. The heterogeneity of radiotherapy prescriptions was significant, and 55% of them did not comply with published recommendations in terms of irradiation dose and/or volume. The proportion of complete responders to induction chemotherapy treated with reduced-dose radiotherapy increased over time. Partial brain radiotherapy was associated with significantly lower overall survival in univariate analysis. In partial responders to induction chemotherapy, increasing the total dose to the brain >30 Gy and adding a boost to the WBRT induced a trend toward improved progression-free and overall survival. Five recurrences (13%) occurred exclusively in the eyes, all in patients whose eyes had been excluded from the irradiation target volume and including 2 patients without ocular involvement at diagnosis., Conclusion: The visibility of recommendations for prescribing brain radiotherapy for the treatment of newly diagnosed primary central nervous system lymphoma needs to be improved to harmonize practices and improve their quality. We propose an update of the recommendations.
- Published
- 2023
- Full Text
- View/download PDF
44. Prognostic Impact of Pretherapeutic FDG-PET in Localized Anal Cancer.
- Author
-
Le Thiec M, Testard A, Ferrer L, Guillerminet C, Morel O, Maucherat B, Rusu D, Girault S, Lacombe M, Hamidou H, Meyer VG, Rio E, Hiret S, Kraeber-Bodéré F, Campion L, and Rousseau C
- Abstract
Due to the heterogeneity of tumour mass segmentation methods and lack of consensus, our study evaluated the prognostic value of pretherapeutic positron emission tomography with fluorodeoxyglucose (FDG-PET) metabolic parameters using different segmentation methods in patients with localized anal squamous cell carcinoma (SCC). Eighty-one patients with FDG-PET before radiochemotherapy were retrospectively analyzed. Semiquantitative data were measured with three fixed thresholds (35%, 41% and 50% of Maximum Standardized Uptake Value (SUVmax)) and four segmentation methods based on iterative approaches (Black, Adaptive, Nestle and Fitting). Metabolic volumes of primary anal tumour (P-MTV) and total tumour load (T-MTV: P-MTV+ lymph node MTV) were calculated. The primary endpoint was event-free survival (EFS). Seven multivariate models were created to compare FDG-PET tumour volumes prognostic impact. For all segmentation thresholds, PET metabolic volume parameters were independent prognostic factor and T-MTV variable was consistently better associated with EFS than P-MTV. Patient's sex was an independent variable and significantly correlated with EFS. With fixed threshold segmentation methods, 35% of SUVmax threshold seemed better correlated with EFS and the best cut-off for discrimination between a low and high risk of event occurrence was 40 cm
3 . Determination of T-MTV by FDG-PET using fixed threshold segmentation is useful for predicting EFS for primary anal SCC. If these data are confirmed in larger studies, FDG-PET could contribute to individualized patient therapies.- Published
- 2020
- Full Text
- View/download PDF
45. High-Dose Hypofractionated Radiation Therapy for Noncompressive Vertebral Metastases in Combination With Zoledronate: A Phase 1 Study.
- Author
-
Pichon B, Campion L, Delpon G, Thillays F, Carrie C, Cellier P, Pommier P, Laude C, Mervoyer A, Hamidou H, Mahé MA, and Supiot S
- Subjects
- Aged, Bone Density Conservation Agents administration & dosage, Combined Modality Therapy, Diphosphonates administration & dosage, Disease-Free Survival, Female, Humans, Imidazoles administration & dosage, Kaplan-Meier Estimate, Male, Pain Measurement, Spinal Cord radiation effects, Spinal Neoplasms mortality, Zoledronic Acid, Bone Density Conservation Agents adverse effects, Diphosphonates adverse effects, Imidazoles adverse effects, Radiation Dose Hypofractionation, Radiosurgery methods, Spinal Neoplasms radiotherapy, Spinal Neoplasms secondary
- Abstract
Introduction: Hypofractionated stereotactic radiation therapy (HSRT) for vertebral metastases gives good results in terms of local control but increases the risk of fracture in the treated volume. Preclinical and clinical studies have shown that zoledronate not only reduces the risk of fracture and stimulates osteoclastic remodeling but also increases the immune response and radiosensitivity. This study aimed to evaluate the tolerability and effectiveness of zoledronate in association with radiation therapy., Patients and Methods: We conducted a multicenter phase 1 study that combined HSRT (3 × 9 Gy) and zoledronate in patients with vertebral metastasis (NCT01219790). The principal objective was the absence of spinal cord adverse reactions at 1 year. The secondary objectives were acute tolerability, the presentation of a bone event, local tumor control, pain control, progression-free survival, and overall survival., Results: Thirty patients (25 male, 5 female), median age 66 years, who were followed up for a median period of 19.2 months, received treatment for 49 vertebral metastases. A grade 3 acute mucosal adverse event occurred in 1 patient during the treatment and in 2 more at 1 month. No late neurologic adverse events were reported at 1 year. The mean pain scores diminished significantly at 1 month (1.35; P=.0125) and 3 months (0.77; P<.0001) compared with pain scores at study entry (2.49). Vertebral collapse in the irradiated zone occurred in 1 (2%) treated vertebra. Control of local disease was achieved in 94% of irradiated patients (3 local recurrences)., Conclusion: The combination of zoledronate and HSRT in the treatment of vertebral metastasis is well tolerated and seems to reduce the rate of vertebral collapse, effectively relieve pain, and achieve good local tumor control with no late neurologic adverse effects., (Copyright © 2016. Published by Elsevier Inc.)
- Published
- 2016
- Full Text
- View/download PDF
46. Definitive chemoradiotherapy in patients with esophageal adenocarcinoma: an alternative to surgery?
- Author
-
Tougeron D, Scotté M, Hamidou H, Di Fiore F, Paillot B, Michot F, and Michel P
- Subjects
- Adenocarcinoma mortality, Adenocarcinoma secondary, Aged, Cisplatin administration & dosage, Combined Modality Therapy, Esophageal Neoplasms mortality, Esophageal Neoplasms pathology, Female, Fluorouracil administration & dosage, Follow-Up Studies, Humans, Lymphatic Metastasis, Male, Middle Aged, Neoplasm Recurrence, Local mortality, Neoplasm Recurrence, Local pathology, Neoplasm Staging, Prognosis, Retrospective Studies, Survival Rate, Adenocarcinoma therapy, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Esophageal Neoplasms therapy, Neoplasm Recurrence, Local therapy
- Abstract
Background and Objectives: Definitive chemoradiotherapy (CRT) is considered curative intent treatment for locally advanced esophageal squamous cell carcinoma. Data concerning the usefulness of definitive CRT in patients with esophageal adenocarcinoma (ADC) are lacking. The aim of the study was to compare the results of definitive CRT versus surgery in patients with an ADC., Methods: All consecutive patients with a non-metastatic ADC treated between 1994 and 2008 were retrospectively assessed. Patients were divided into two groups: surgery group (±pre-operative treatment) versus definitive CRT group., Results: In surgery and definitive CRT groups, 67 and 79 patients were evaluated, respectively. A complete resection was achieved in 92.5% of patients in surgery group and a clinical complete response was observed in 49.4% of patients in definitive CRT group. Overall survival was 36.2 ± 2.0 months in surgery group versus 16.5 ± 0.8 months in definitive CRT group (P = 0.02). The predictive factors of survival were age (P < 0.01), stage (P = 0.04), WHO performance status (P < 0.01), initial weight loss (P < 0.01), and the treatment group (P < 0.01)., Conclusions: The results of the study do not support definitive CRT as an alternative to surgery in esophageal ADC treatment. Definitive CRT should be reserved for patients with a major operative risk., (Copyright © 2011 Wiley Periodicals, Inc.)
- Published
- 2012
- Full Text
- View/download PDF
47. Safety and outcome of chemoradiotherapy in elderly patients with rectal cancer: results from two French tertiary centres.
- Author
-
Tougeron D, Roullet B, Paillot B, Hamidou H, Tourani JM, Bensadoun RJ, Michel P, and Silvain C
- Subjects
- Aged, Aged, 80 and over, Capecitabine, Deoxycytidine analogs & derivatives, Deoxycytidine therapeutic use, Disease-Free Survival, Female, Fluorouracil analogs & derivatives, Fluorouracil therapeutic use, France, Humans, Kaplan-Meier Estimate, Leucovorin therapeutic use, Male, Neoplasm Metastasis, Neoplasm Staging, Organoplatinum Compounds therapeutic use, Oxaliplatin, Retrospective Studies, Tegafur therapeutic use, Vitamin B Complex therapeutic use, Antineoplastic Agents therapeutic use, Chemoradiotherapy, Adjuvant adverse effects, Rectal Neoplasms pathology, Rectal Neoplasms therapy
- Abstract
Background: The risks of chemoradiotherapy in elderly patients with rectal cancer have not yet been well-characterised., Methods: We retrospectively reviewed the charts of patients with rectal cancer over 70 years old who were treated with chemoradiotherapy in two French university hospitals., Results: A total of 125 patients were evaluated. Mean age was 75.1 ± 4.1 years and ranged from 70 to 90 years. Adverse effects ≥ grade 2 were observed in 32% of the patients and adverse effects ≥ grade 3 in 15%. Dose reduction for toxicity was performed in 18% of the patients and chemoradiotherapy discontinuation was necessary in 9%. Postoperative morbidity was 16% with two treatment-related deaths. Two-year survival rate was 84%. No variables had any influence on treatment-related adverse events., Conclusions: In selected elderly patients, chemoradiotherapy is well-tolerated, without any significant increase in adverse events, and the results are similar to those recorded in younger patients., (Copyright © 2011 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
48. Basaloid squamous cell carcinoma of the head and neck: report of 18 cases.
- Author
-
Choussy O, Bertrand M, François A, Blot E, Hamidou H, and Dehesdin D
- Subjects
- Aged, Aged, 80 and over, Carcinoma, Basosquamous epidemiology, Carcinoma, Basosquamous pathology, Carcinoma, Basosquamous therapy, Combined Modality Therapy, Diagnosis, Differential, Disease Progression, Female, Head and Neck Neoplasms epidemiology, Head and Neck Neoplasms pathology, Head and Neck Neoplasms therapy, Humans, Immunohistochemistry, Kaplan-Meier Estimate, Male, Middle Aged, Neoplasm Metastasis, Neoplasm Staging, Retrospective Studies, Risk Factors, Staining and Labeling, Survival Rate, Carcinoma, Basosquamous diagnosis, Head and Neck Neoplasms diagnosis
- Abstract
Objective: To evaluate the clinical course and pathological characteristics of basaloid head and neck squamous cell carcinoma., Method: Retrospective study of 18 cases of basaloid head and neck squamous cell carcinoma. Epidemiological, clinical and histological data were analysed and the Kaplan-Meier test used to estimate survival rates., Results: The majority of lesions were at an advanced stage. These lesions were primarily localised in the larynx, hypopharynx and oropharynx. Routine pre-therapeutic assessment of squamous cell carcinoma was performed. Pathological diagnosis was difficult, although immunostaining was extremely useful. Positive staining for KL1, MNF 116 and 34βE12 and negative immunostaining for chromogranin and synaptophysin were also important factors in obtaining a definitive diagnosis. In the majority of cases, treatment involved surgery and radiotherapy. The five-year survival rate was 5 per cent., Conclusion: Basaloid squamous cell carcinoma is an uncommon head and neck lesion, with a challenging histological diagnosis. These lesions must be carefully monitored due to their aggressive course, and require multimodality treatment.
- Published
- 2011
- Full Text
- View/download PDF
49. Esophageal cancer in the elderly: an analysis of the factors associated with treatment decisions and outcomes.
- Author
-
Tougeron D, Hamidou H, Scotté M, Di Fiore F, Antonietti M, Paillot B, and Michel P
- Subjects
- Aged, Aged, 80 and over, Antineoplastic Agents adverse effects, Female, Geriatrics methods, Humans, Male, Medical Oncology methods, Middle Aged, Models, Statistical, Neoplasm Metastasis, Palliative Care, Retrospective Studies, Treatment Outcome, Esophageal Neoplasms epidemiology, Esophageal Neoplasms therapy
- Abstract
Background: Only limited data has been reported so far regarding oesophageal cancer (EC) in elderly patients. The aim of the study is to identify the baseline parameters that influenced therapeutic decision., Methods: All consecutive patients 70 years or older being treated for EC were retrospectively analyzed. Patients without visceral metastasis were divided into two groups: treatment with curative intent (chemoradiotherapy, surgery, radiotherapy, mucosectomy or photodynamic therapy) or best supportive care (BSC). Patients with metastasis were divided into two groups: palliative treatment (chemotherapy, chemoradiotherapy or radiotherapy) or BSC., Results: Two hundred and eighty-two patients were studied. Mean age was 76.5 ± 5.5 years and 22.4% of patients had visceral metastasis. In patients without visceral metastasis (n = 220) the majority had treatment with curative intent (n = 151) whereas in patients with metastasis (n = 62) the majority had BSC (n = 32). Severe adverse events (≥ grade 3) were observed in only 17% of the patients. Patients without specific carcinologic treatment were older, had more weight loss, worse WHO performance status and Charlson score in multivariate analysis., Discussion: Our results suggest that elderly patients with an EC could benefit from cancer treatment without major toxicities. Weight loss, WHO performance status and the Charlson score could be used to select the appropriate treatment in an elderly patient.
- Published
- 2010
- Full Text
- View/download PDF
50. Control of pelvic symptoms in patients with rectal cancer and synchronous metastases.
- Author
-
Tougeron D, Di Fiore F, Lefebure B, Hamidou H, Tuech JJ, Michot F, Paillot B, and Michel P
- Subjects
- Aged, Combined Modality Therapy, Female, Humans, Male, Middle Aged, Neoplasm Metastasis, Pelvis, Rectal Neoplasms complications, Rectal Neoplasms drug therapy, Rectal Neoplasms pathology, Rectal Neoplasms radiotherapy, Rectal Neoplasms surgery, Retrospective Studies, Rectal Neoplasms therapy
- Abstract
Objective: The optimal treatment strategy for rectal cancer (RC) with synchronous metastases remains an issue of debate. The aim of this study was to evaluate the impact of surgery and radiation on the control of pelvic symptoms in this setting., Methods: Consecutive patients with RC and synchronous metastases were retrospectively assessed and divided into four treatment groups: surgical resection of rectal tumor (S); radiotherapy with/without chemotherapy followed by surgery (CRTS); chemoradiotherapy (CRT); and chemotherapy only (CT). Each group was evaluated in terms of duration of pelvic symptom-free periods (relative to overall survival)., Results: A total of 96 patients were evaluated: S: n=30; CRTS: n=21; CRT: n=27; and CT: n=18. After treatment, pelvic symptoms persisted in 14.7% patients (S=0%, CRTS=7.1%, CRT=31.8%, CT=25%; P=0.01). The relative pelvic symptom-free periods were 93.0% in the S group, 83.1% in the CRTS group, 53.0% in the CRT group and 53.2% in the CT group (P<0.01). On multivariate analysis, only surgical treatment correlated with a significant relative pelvic symptom-free period (P<0.01), with an adjusted hazards ratio of 2.80 [95% CI: 1.79-4.39]., Conclusion: Our results suggest that rectal resection was the most effective therapeutic procedure in selected patients with RC and synchronous metastases, offering the patients the longest pelvic symptom-free periods.
- Published
- 2009
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.